文献速递头颈部肿瘤放疗放疗物理与技术

头颈部自适应质子治疗端到端测试的多用途体模框架

A versatile phantom-based framework for end-to-end testing of (online) adaptive proton therapy in the head-and-neck region.
PubMed 文献 · Radiother Oncol · 2026-08-26

本研究设计了一种3D打印头颈部体模,用于测试多种自适应质子治疗工作流程的效能。在六家机构中,采用电离室和辐射变色胶片测量剂量退化与恢复,结果显示不 adapt 解剖变化导致靶区剂量中位下降13.9%,适应后靶区差异中位0.2%。该体模与端到端测试框架能可靠检测解剖变化的剂量学效应,并在六家机构间提供可比结果。

要点

  • 体模可模拟头颈部腔隙填充和肿胀变化,用于端到端测试自适应质子治疗流程。
  • 不适应解剖变化时靶区剂量中位下降13.9%,适应后靶区差异中位仅0.2%。
  • 六家机构测试结果可比,支持多种自适应工具如日志文件剂量重建和CBCT合成CT。

核心结论

  • 多用途体模与端到端测试框架能可靠检测解剖变化的剂量学效应,并在六家机构间提供可比结果。

研究设计与样本

  • 设计了一种自定义3D打印头颈部体模,模拟不同腔隙填充和肿胀,在六家机构中比较基线场景与解剖改变场景(初始计划和适应计划)的剂量退化与恢复。

主要发现

  • 电离室测量与计算的中位剂量偏差为-0.7%[IQR=1.2%],各机构和场景平均无显著差异。
  • 不适应解剖变化导致靶区内中位剂量下降13.9%[IQR=1.5%],建成区中位剂量增加169.2%[IQR=11.7%]。
  • 适应解剖变化后,靶区中位差异为0.2%[IQR=0.8%],建成区最大差异为3.3%。
  • 辐射变色胶片测量的Gamma通过率(2%, 2mm)分析显示可比趋势。

关键数值与推荐

  • Gamma通过率分析采用2%剂量差异和2mm距离标准。
  • 电离室与计算剂量偏差中位-0.7%[IQR=1.2%],适应后靶区差异中位0.2%[IQR=0.8%]。

临床怎么用

  • 该框架可用于机构特异性端到端测试,验证自适应质子治疗工作流程对解剖变化的剂量学检测能力。
  • 支持整合日志文件剂量重建、CBCT合成CT、瞬发伽马成像和质子成像等工具,依据可用性选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Clinical implementation of online adaptive proton therapy requires rigorous testing of all facility-specific components. This work aimed to develop a multi-purpose phantom-based framework capable of testing the efficacy of diverse adaptive proton therapy workflows. MATERIALS AND METHODS: A custom-built, 3D-printed phantom mimicking different cavity fillings and swelling in the head-and-neck region was designed. The baseline scenario was compared with the anatomically altered scenario employing an initial and an adapted treatment plan. Across six institutes, dose deterioration and recovery were measured using an ionisation chamber and radiochromic films. Tools supporting adaptive proton therapy, i.e. log-file-based dose reconstruction, cone-beam computed tomography (CBCT)-based synthetic CTs, prompt- gamma imaging and proton radiography were included depending on their availability to demonstrate the framework's versatility. RESULTS: Median dose deviation between ionisation chamber measurements and calculation was -0.7%[IQR=1.2%] averaged over all institutes and scenarios without significant differences. Not adapting to the anatomical change led to a 13.9%[IQR=1.5%] median dose decrease inside the target and 169.2%[IQR=11.7%] in the buildup region. Adapting to the changed anatomy, a median 0.2%[IQR=0.8 %] difference in the target and maximum 3.3% in the buildup could be achieved. Gamma-pass-rate (2%, 2mm) analysis of the radiochromic film measurements revealed a comparable trend. Institute-specific tests showed good compatibility with the various adaptive workflows tools. CONCLUSIONS: The combination of the developed multi-purpose phantom and the end-to-end testing framework could reliably detect dosimetric effects of anatomical changes and provided comparable results across six institutes.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Brunner J, Albertini F, Bernardini GP, et al. A versatile phantom-based framework for end-to-end testing of (online) adaptive proton therapy in the head-and-neck region. Radiother Oncol. 2026. PMID: 42648646. doi:10.1016/j.radonc.2026.111749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。